Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria Escherichia coli O83 (Colinfant)

. 2009 ; 54 (4) : 359-63. [epub] 20091014

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid19826925

A certain relationship was observed between the gastrointestinal system, arthritis and immune system. Patients with rheumatoid arthritis have an altered microflora composition and disturbed intestinal defensive barrier. Effect of probiotic bacteria (Colinfant; COL) with known favorable effect on intestinal microflora was determined on the methotrexate (MTX) treatment of adjuvant arthritis. Rats with adjuvant arthritis were administered methotrexate 0.5 mg/kg body mass 2-times weekly per os, COL 1 mL/kg body mass every second day per os, and a combination of MTX+COL for a period of 28 d from the immunization. Levels of serum albumin, body mass, changes in hind paw swelling, and arthrogram score were estimated in rats as variables of inflammation and destructive arthritis-associated changes. Treatment with MTX, as well as with the combination treatment with MTX+COL significantly inhibited both inflammation and destructive arthritis-associated changes. The combination treatment inhibited both the hind paw swelling and arthrogram score more remarkably than MTX alone; on the other hand, the difference between combination treatment and MTX alone was not significant. Treatment with COL alone had no effect on adjuvant arthritis in rats. Colinfant can increase the preventive effect of MTX treatment in rat adjuvant arthritis by improving its antiarthritic effects.

Zobrazit více v PubMed

Surgery. 2001 Nov;130(5):859-65 PubMed

Curr Opin Rheumatol. 1991 Jun;3(3):407-20 PubMed

Clin Microbiol Rev. 2003 Oct;16(4):658-72 PubMed

Folia Microbiol (Praha). 2007;52(6):618-26 PubMed

Am J Clin Nutr. 1999 May;69(5):1046S-1051S PubMed

Scand J Rheumatol. 2003;32(4):211-5 PubMed

Am J Clin Nutr. 2001 Feb;73(2 Suppl):444S-450S PubMed

Biol Neonate. 1997;71(4):224-32 PubMed

Mol Immunol. 2008 May;45(9):2690-9 PubMed

Folia Microbiol (Praha). 2006;51(5):478-84 PubMed

Inflammopharmacology. 1997;5(3):219-36 PubMed

Folia Microbiol (Praha). 2007;52(2):189-93 PubMed

Immunol Lett. 2004 May 15;93(2-3):97-108 PubMed

Br J Rheumatol. 1994 Nov;33(11):1030-8 PubMed

Gastroenterology. 1996 Aug;111(2):334-44 PubMed

Int J Immunopharmacol. 1988;10(6):717-28 PubMed

Immunopharmacology. 1988 May-Jun;15(3):133-42 PubMed

Int Arch Allergy Immunol. 2003 Jul;131(3):209-11 PubMed

Aliment Pharmacol Ther. 1997 Dec;11 Suppl 3:17-22; discussion 22-3 PubMed

Br J Rheumatol. 1997 Jan;36(1):64-8 PubMed

Ann N Y Acad Sci. 2005 Jun;1051:570-81 PubMed

Ann Rheum Dis. 2003 May;62(5):423-6 PubMed

J Rheumatol. 1985 Oct;12(5):904-6 PubMed

J Food Prot. 2002 Jan;65(1):153-60 PubMed

J Altern Complement Med. 2002 Feb;8(1):71-5 PubMed

Folia Microbiol (Praha). 2002;47(5):573-8 PubMed

Folia Microbiol (Praha). 2008;53(3):189-94 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...